Target intelligence / Profile preview

ASH2 like, histone lysine methyltransferase complex subunit (ASH2L)

Target
ASH2L
Molecular classification
Histone modification, Enzyme (specifically, a methyltransferase complex subunit), Transcription complex component
01

Overview

ASH2 like, histone lysine methyltransferase complex subunit (ASH2L), is a **core component of the COMPASS/MLL family of histone methyltransferase complexes** responsible for methylation of histone H3 at lysine 4 (H3K4), a critical mark for active gene transcription[1][2][3]. ASH2L enables the catalytic activity of the MLL family enzymes by serving as a scaffold and regulator within multiprotein complexes that include WDR5, RBBP5, and DPY30[3]. It contains a plant homeodomain (PHD) finger and a SPRY domain, with an atypical PHD that does not directly bind histone tails, as well as a DNA-binding winged-helix motif critical for chromatin localization and gene regulation[1]. ASH2L functions both in general chromatin accessibility and in **direct transcriptional enhancement** by associating with specific transcription factors (e.g., Ap2δ) that recruit MLL/COMPASS complexes to particular gene promoters, facilitating targeted H3K4 trimethylation and gene activation[2]. Loss or mutation of ASH2L disrupts H3K4 methylation, represses gene expression (especially at CpG island promoters), alters chromatin architecture, and can lead to cellular senescence or developmental defects[3].

Other names
ASH2LASH2L1ASH2L2Bre2Set1/Ash2 histone methyltransferase complex subunit ASH2ASH2-like proteinash2 (absent, small, or homeotic)-like
02

Mechanism of action

Involved in recruitment of methyltransferase complexes (e.g., MLL complex) for H3K4 methylation Complexes with transcription factors (e.g., Ap2δ) to mediate specific promoter methylation/gene activation

03

Biological functions

Histone H3K4 methylationRegulation of gene transcriptionChromatin modificationPromoter accessibilityChromatin domain demarcation
04

Disease associations

CancerCell senescenceDevelopmental disordersOther gene expression-related diseases
05

Safety considerations

Loss of ASH2L leads to widespread gene repression and can induce cellular senescenceDisruption may affect development and tissue homeostasis
06

Biomarkers

Reduced H3K4me3 (trimethylation at lysine 4 of histone H3) at promoters is a biomarker for loss of ASH2L functionChanges in chromatin accessibilityCpG island promoter repression

Beyond the preview

Go deeper on ASH2 like, histone lysine methyltransferase complex subunit (ASH2L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASH2 like, histone lysine methyltransferase complex subunit (ASH2L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call